CoChat

Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision

Boy, Nikolas, Mühlhausen, Chris, Maier, Esther M., Heringer, Jana, Assmann, Birgit, Burgard, Peter, Dixon, Marjorie, Fleissner, Sandra, Greenberg, Cheryl R., Harting, Inga, Hoffmann, Georg F., Karall, Daniela, Koeller, David M., Krawinkel, Michael B., Okun, Jürgen G., Opladen, Thomas, Posset, Roland, Sahm, Katja, Zschocke, Johannes, Kölker, Stefan, Additional individual contributors · 2017 · Journal of Inherited Metabolic Disease
Cited by 229

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Glutaric aciduria type I (GA‐I; synonym, glutaric acidemia type I) is a rare inherited metabolic disease caused by deficiency of glutaryl‐CoA dehydrogenase located in the catabolic pathways of L‐lysine, L‐hydroxylysine, and L‐tryptophan. The enzymatic defect results in elevated concentrations of glutaric acid, 3‐hydroxyglutaric acid, glutaconic acid, and glutaryl carnitine in body tissues, which can be reliably detected by gas chromatography/mass spectrometry (organic acids) and tandem mass spectrometry (acylcarnitines). Most untreated individuals with GA‐I experience acute encephalopathic crises during the first 6 years of life that are triggered by infectious diseases, febrile reaction to vaccinations, and surgery. These crises result in striatal injury and consequent dystonic movement disorder; thus, significant mortality and morbidity results. In some patients, neurologic disease may also develop without clinically apparent crises at any age. Neonatal screening for GA‐I us being used in a growing number of countries worldwide and is cost effective. Metabolic treatment, consisting of low lysine diet, carnitine supplementation, and intensified emergency treatment during catabolism, is effective treatment and improves neurologic outcome in those individuals diagnosed early; treatment after symptom onset, however, is less effective. Dietary treatment is relaxed after age 6 years and should be supervised by specialized metabolic centers. The major aim of this second revision of proposed recommendations is to re‐evaluate the previous recommendations (Kölker et al. J Inherit Metab Dis 30:5‐22, 2007b; J Inherit Metab Dis 34:677‐694, 2011) and add new research findings, relevant clinical aspects, and the perspective of affected individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10545-016-9999-9

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Metadata

Authors
Boy, N., Mühlhausen, C., Maier, E. M., Heringer, J., Assmann, B., Burgard, P., Dixon, M., Fleissner, S., Greenberg, C. R., Harting, I., Hoffmann, G. F., Karall, D., Koeller, D. M., Krawinkel, M. B., Okun, J. G., Opladen, T., Posset, R., Sahm, K., Zschocke, J., Kölker, S., & contributors, A. I.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2016-11-16
Volume
40
Issue
1
Pages
75-101
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2549943931
Cited by
229
References
4
FWCI
12.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. https://app.cochat.ai/papers/10.1007/s10545-016-9999-9
The paper
Boy, N., Mühlhausen, C., Maier, E. M., Heringer, J., Assmann, B., Burgard, P., Dixon, M., Fleissner, S., Greenberg, C. R., Harting, I., Hoffmann, G. F., Karall, D., Koeller, D. M., Krawinkel, M. B., Okun, J. G., Opladen, T., Posset, R., Sahm, K., Zschocke, J., . . . contributors, A. I. (2017). Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-016-9999-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.